BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3509393)

  • 1. Comparison of serum bactericidal activities of three experimental antibiotic regimens against Corynebacterium group JK.
    Chantrenne ML; De Knop RJ; Van Caekenberghe DL; Wouters RM
    Chemioterapia; 1987 Jun; 6(2 Suppl):23-5. PubMed ID: 3509393
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sensitivity curves of multiply resistant corynebacteria JK and D2].
    Rauturier M; Darbas H; Jean-Pierre H; Boyer G; Rivière M
    Pathol Biol (Paris); 1990 May; 38(5):420-5. PubMed ID: 2142275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
    Zuravleff JJ; Yu VL; Yee RB
    J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetics of bactericidial function of cefotaxim against Pseudomonas aeruginosa alone and in combination with tobramycin].
    Shah PM; Troche G; Stille W
    Med Welt; 1980 Aug; 31(35):1244-5. PubMed ID: 6252415
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro synergy of cefazolin-tobramycin against gram-positive bacteria.
    Collins RF; Edwards LD
    J Antimicrob Chemother; 1980 May; 6(3):323-31. PubMed ID: 7400067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Species composition and antibiotic sensitivity of staphylococci isolated from patients with furunculosis].
    Kutsyk RV; Kurovets' LM
    Mikrobiol Z; 2002; 64(5):59-62. PubMed ID: 12557495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.
    Pavillard ER; Miles H
    Clin Ther; 1980; 3(Spec Issue):134-8. PubMed ID: 6446387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy of an ophthalmic drug combination against corneal pathogens of horses.
    Scotty NC; Brooks DE; Schuman Rose CD
    Am J Vet Res; 2008 Jan; 69(1):101-7. PubMed ID: 18167094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
    Gagnon RF; Richards GK; Kostiner GB
    Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro study of synergistic activity between netilmicin and tobramycin combined with ceftriaxone versus Pseudomonas and Serratia species.
    Focà A; Carbone M; Mastroeni P
    Chemioterapia; 1987 Jun; 6(2 Suppl):123-4. PubMed ID: 3509368
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between group JK corynebacteria and the biotypes of Corynebacterium genitalium and Corynebacterium pseudogenitalium.
    Evangelista AT; Coppola KM; Furness G
    Can J Microbiol; 1984 Aug; 30(8):1052-7. PubMed ID: 6498640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of twelve burn wound infections and eight other serious infections with cefazolin and tobramycin: in vitro and in vivo evaluation.
    Franson TR; Edwards LD; Collins RF; Root TE
    Chemotherapy; 1980; 26(5):384-96. PubMed ID: 7389430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.
    Pankey G; Ashcraft D; Patel N
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5166-8. PubMed ID: 16304195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and interval of exposure.
    Li RC; Tang MC
    J Antimicrob Chemother; 2004 Nov; 54(5):904-8. PubMed ID: 15375112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of opportunistic species of the Corynebacterium and related coryneforms isolated from different clinical materials.
    Chudnicka A; Kozioł-Montewka M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):385-91. PubMed ID: 15315020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model.
    Zelenitsky SA; Iacovides H; Harding GK; Ariano RE
    Diagn Microbiol Infect Dis; 2004 May; 49(1):67-70. PubMed ID: 15135504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of Corynebacterium striatum endocarditis with daptomycin plus rifampin.
    Shah M; Murillo JL
    Ann Pharmacother; 2005 Oct; 39(10):1741-4. PubMed ID: 16144879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.